<DOC>
	<DOCNO>NCT00195338</DOCNO>
	<brief_summary>The purpose study determine long term safety Enbrel adult active rheumatoid arthritis Luxemburg . This post-marketing surveillance study rheumatology practice patient . All patient initiate Enbrel observe start study Feb 2003 period least 5 year .</brief_summary>
	<brief_title>Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Have moderate severe active rheumatoid arthritis Be age 17 year Have inadequate response DMards Give write informed consent Physician decide prescribe Enbrel</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>